A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22864465
Conclusion of this study
The current study suggests that creatine augmentation of SSRI treatment may be a promising therapeutic approach that exhibits more rapid and efficacious responses in women with major depressive disorder.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study